Transpek

Vadodara, India Founded: 1965 • Age: 61 yrs Listed
Manufacturer of agrochemicals, polymers, pharmaceuticals, dyestuff, and surfactants
Request Access
Report Incorrect Data
Page last updated

About Transpek

Transpek is a publicly listed company based in Vadodara (India) founded in 1965. Manufacturer of agrochemicals, polymers, pharmaceuticals, dyestuff, and surfactants. The company has 930 employees. Its Indian entity Transpek Industry Limited reported revenue of ₹646 Cr. Transpek offers products and services including Thionyl Chloride, Acid Chlorides, and Alkyl Chlorides. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.

Company details

Transpek, established in 1965 and currently in Public stage, focuses on chemicals and materials, diversified chemicals, and diversified. Manufacturer of agrochemicals, polymers, pharmaceuticals, dyestuff, and surfactants. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Vadodara, India
  • Employees 930
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website transpek.com
  • Legal Name Transpek Industry Limited
Operational Areas
Chemicals & Materials → Core & Diversified Chemicals
Key Metrics
  • Market Cap
    ₹721 Cr

    TRANSPEK · BSE

  • Share Price
    ₹1,292.00

    +0.06% today

  • Revenue
    ₹621 Cr

    FY 2025-26 · -4.4% YoY

  • EBITDA
    ₹93.39 Cr

    Margin 15.0%

  • Net Profit
    ₹46.46 Cr

    FY 2025-26 · -13.8% YoY

  • P/E (TTM)
    18.0x

    P/B 0.9x

  • ROE
    6.0%

    ROCE 8.2%

  • Debt / Equity
    0.11

    Interest cover 18.0x

  • Employee Count
    930

Products & Services of Transpek

Transpek offers a comprehensive portfolio of products and services, including Thionyl Chloride, Acid Chlorides, and Alkyl Chlorides.

Thionyl Chloride
Chemical Product

Chlorinated chemical used in pharmaceuticals and agrochemicals

Acid Chlorides
Chemical Product

Compounds for polymer and pharmaceutical applications

Alkyl Chlorides
Chemical Product

Chemicals supplied for dyestuff and surfactants industries

Board of directors of Transpek Industry Limited (Transpek)

Transpek Industry Limited is the primary company behind Transpek. The boards of the 2 registered companies of Transpek currently have 13 directors; the longest-serving is Ashwin Champraj Shroff, appointed in 1980. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashwin Champraj Shroff
DIN 00019952
Director02 May 198046 yrs 6 moTranspek Industry Limited
Dipesh Kantisen Shroff
DIN 00030792
Director27 Mar 200125 yrs 7 moTranspek Industry Limited
Ravi Ashwin Shroff
DIN 00033505
Director29 Mar 200818 yrs 7 moTranspek Industry Limited
Bimal Vasantlal Mehta
DIN 00081171
Managing Director13 Aug 201016 yrs 2 moTranspek Industry Limited
Anandmohan Tiwari
DIN 02986260
Director04 Nov 20197 yrsTranspek Industry Limited
Sharad Rajaram Patil
DIN 08659503
Director06 Jan 20206 yrs 10 moTranspek Creative Chemistry Private Limited
Radhakrushna Bhujanga Shetty
DIN 08659504
Director06 Jan 20206 yrs 10 moTranspek Creative Chemistry Private Limited
Hemantkumar Jayantiprasad Bhatt
DIN 02657432
Director06 Jan 20206 yrs 10 moTranspek Creative Chemistry Private Limited
Avtar Singh
DIN 00063569
Whole-time director01 Oct 20215 yrs 1 moTranspek Industry Limited
Rajeev Mahendra Pandia
DIN 00021730
Director09 Aug 20242 yrs 2 moTranspek Industry Limited
Vijay Maniar
DIN 00750905
Director09 Aug 20242 yrs 2 moTranspek Industry Limited
Rita Amitabh Teaotia
DIN 02876666
Director09 Aug 20242 yrs 2 moTranspek Industry Limited
Maulik Deepak Mehta
DIN 05227290
Director09 Aug 20242 yrs 2 moTranspek Industry Limited

People of Transpek

23 people are tracked at Transpek (6 in leadership, 9 in board & advisors, 8 in team); the tracked headcount is 930.

NameRoleGroup
Bimal V. Mehta
Managing DirectorLeadership
Paresh Shaparia
Assistant General Manager-solution, ImprovementLeadership
Jeet Saini
Head ElectricalLeadership
Pratik Shah
VP FinanceLeadership
Ashok Jadeja
Vice President - CommercialLeadership
Sharad Patil
Vice PresidentLeadership
Anandmohan Tiwari
DirectorBoard & advisors
Atul G. Shroff
DirectorBoard & advisors
Dipesh K. Shroff
DirectorBoard & advisors
Nimish U. Patel
DirectorBoard & advisors
Hemant J. Bhatt
DirectorBoard & advisors
Bernd Dill
DirectorBoard & advisors
Ninad D. Gupte
DirectorBoard & advisors
Geeta A. Goradia
DirectorBoard & advisors
Ravi Ashwin Shroff
DirectorBoard & advisors
Nikhil Katdare
Manager- Projects & DevelopmentTeam
Vijay Patel
Senior Manager QMTeam
Amisha Patel
Senior Account OfficerTeam
Tushar Pansuriya
Graduate Engineering TraineeTeam
Niyati Shroff
Process EngineerTeam

3 more people are available in the full profile.

Premium access

Complete people profiles for Transpek

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Transpek

Transpek is a publicly listed company on the BSE with ticker symbol TRANSPEK in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date04 Nov 1979
  • Listed onBSE: 506687
  • Listed entityTranspek Industry Limited
  • Exchange sectorProcess industries
  • ISININE687A01016
  • Share price₹1,207.00 (-1.75% on the day) · 2026-05-11
  • Market capitalisation₹691 Cr
  • Price to earnings11.6
  • EPS (diluted, trailing year)₹104.41
  • Dividend yield1.62%
  • Volume (last session)737
  • Analyst consensusNo rating

Financials of Transpek

Exchange-reported figures of Transpek Industry Limited, the listed company behind Transpek (BSE: TRANSPEK).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹621 Cr
-4.4% YoY
EBITDA
₹93.39 Cr
-1.4% YoY
Profit After Tax
₹46.46 Cr
-13.8% YoY
Net Worth
₹767 Cr
+3.0% YoY
Total Assets
₹845 Cr
+0.3% YoY
Total Debt
₹74.43 Cr
-21.2% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue621650580827599339566
Revenue growth-4.4%+12.1%-29.9%+38.0%+76.5%-40.0%-
EBITDA93.3994.6782.3114796.1247.19118
EBITDA margin+15.0%+14.6%+14.2%+17.8%+16.0%+13.9%+20.8%
Profit before tax61.1961.6555.5211384.2325.5393.52
Net profit46.4653.8938.3385.4768.7222.4873.36
Net profit margin+7.5%+8.3%+6.6%+10.3%+11.5%+6.6%+13.0%
EPS (₹)81.7287.2569.03149.45117.0941.74130.59
Balance sheet
Total assets845843799735625494468
Net worth767745673587484380338
Total debt74.4394.46123145137111116
Cash & bank11510130.6025.4851.0022.201.12
Net working capital24922115216217410794.44
Cash flow
Cash from operations78.4713597.8011147.1034.52111
Cash from investing(37.50)(30.46)(31.52)(13.02)(70.10)(16.76)(33.17)
Cash from financing(39.65)(56.17)(63.69)(93.91)9.21(2.70)(77.24)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue151148158160154165170163
Revenue growth (YoY)-2.1%-10.3%-6.8%-1.5%+1.6%---
Other income4.004.273.545.0311.667.744.895.09
EBITDA20.1417.7324.9326.6824.0532.2223.9422.52
EBITDA margin+13.3%+12.0%+15.7%+16.6%+15.6%+19.5%+14.1%+13.8%
Depreciation10.8411.6412.3412.3412.3212.6412.1312.89
Interest1.521.521.672.412.462.793.122.82
Profit before tax11.788.8414.4616.9620.9324.5313.5811.90
Tax2.862.253.624.335.355.272.932.34
Net profit8.926.5910.8412.6315.5819.2610.659.56
EPS (₹)15.9811.7819.4222.6227.9034.4719.0617.10
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue621650580827599339566
Revenue growth-4.4%+12.1%-29.9%+38.0%+76.5%-40.0%-
EBITDA93.3994.6882.3214796.1247.24118
EBITDA margin+15.0%+14.6%+14.2%+17.8%+16.0%+13.9%+20.8%
Profit before tax61.1961.6655.5311384.2325.5393.52
Net profit46.4653.9038.3485.4868.7222.4873.36
Net profit margin+7.5%+8.3%+6.6%+10.3%+11.5%+6.6%+13.0%
EPS (₹)81.7287.2669.04149.46117.0941.74130.59
Balance sheet
Total assets845843799735625494468
Net worth767745673587484380338
Total debt74.4394.46123145137111126
Cash & bank11510130.5625.4851.0022.111.12
Net working capital24922115216217410794.44
Cash flow
Cash from operations78.4713597.8011147.1034.43111
Cash from investing(37.50)(30.46)(31.56)(13.02)(70.11)(16.76)(33.35)
Cash from financing(39.65)(56.17)(63.69)(93.91)9.22(2.70)(77.24)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue151148158160154165170163
Revenue growth (YoY)-2.1%-10.3%-6.8%-1.5%+1.6%---
Other income4.004.273.545.0311.667.744.895.09
Total expenses131130134134130133146140
EBITDA20.1417.7324.9326.6824.0532.2223.9422.52
EBITDA margin+13.3%+12.0%+15.7%+16.6%+15.6%+19.5%+14.1%+13.8%
Depreciation10.8411.6412.3412.3412.3212.6412.1312.89
Interest1.521.521.672.412.462.793.122.82
Profit before tax11.788.8414.4616.9620.9324.5313.5811.90
Tax2.862.253.624.335.355.272.932.34

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue151148158160154165170163
Revenue growth (YoY)-2.1%-10.3%-6.8%-1.5%+1.6%---
Other income4.004.273.545.0311.667.744.895.09
EBITDA20.1417.7324.9326.6824.0532.2223.9422.52
EBITDA margin+13.3%+12.0%+15.7%+16.6%+15.6%+19.5%+14.1%+13.8%
Depreciation10.8411.6412.3412.3412.3212.6412.1312.89
Interest1.521.521.672.412.462.793.122.82
Profit before tax11.788.8414.4616.9620.9324.5313.5811.90
Tax2.862.253.624.335.355.272.932.34
Net profit8.926.5910.8412.6315.5819.2610.659.56
EPS (₹)15.9811.7819.4222.6227.9034.4719.0617.10
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue621650580827599339566
Revenue growth-4.4%+12.1%-29.9%+38.0%+76.5%-40.0%-
Other income24.5028.7125.1617.8128.3817.2617.39
Total expenses528555497680503292448
Employee cost73.2666.6361.5860.3051.5144.8749.42
EBITDA93.3994.6782.3114796.1247.19118
EBITDA margin+15.0%+14.6%+14.2%+17.8%+16.0%+13.9%+20.8%
Depreciation48.6449.9937.6033.0229.7328.5125.90
Interest8.0611.7414.3519.2310.5410.4115.85
Profit before tax61.1961.6555.5211384.2325.5393.52
Tax15.5512.9216.9529.3218.842.2320.58
Net profit46.4653.8938.3385.4768.7222.4873.36
Net profit margin+7.5%+8.3%+6.6%+10.3%+11.5%+6.6%+13.0%
EPS (₹)81.7287.2569.03149.45117.0941.74130.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital5.595.595.595.595.595.595.59
Reserves & surplus762740668581479374333
Shareholders' funds (net worth)767745673587484380338
Minority interest0.000.000.000.000.000.000.00
Secured loans17.468.7710.2241.9592.4962.4772.59
Unsecured loans56.9785.6911310344.5548.3843.83
Total debt74.4394.46123145137111116
Total liabilities845843799735625494468
Assets
Gross block557528530465404370343
Net block343360397365295287287
Capital work in progress4.605.076.1424.1516.0713.9318.63
Investments316328321238196142118
Inventories50.3267.1364.3565.2366.1536.7249.67
Sundry debtors15010391.8611899.1876.1289.75
Cash & bank balances11510130.6025.4851.0022.201.12
Loans & advances20.7629.9426.8225.5327.7318.6818.04
Total current assets337301214234244154159
Total current liabilities87.5080.1361.9472.1169.6846.9864.14
Net working capital24922115216217410794.44
Total assets845843799735625494468
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash56.528.085.501.6015.390.420.23
Net cash from operating activities78.4713597.8011147.1034.52111
Net cash from investing activities(37.50)(30.46)(31.52)(13.02)(70.10)(16.76)(33.17)
Net cash from financing activities(39.65)(56.17)(63.69)(93.91)9.21(2.70)(77.24)
Net change in cash1.3148.442.593.90(13.79)15.060.19
Closing cash11510130.6025.4851.0022.201.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-4.4%+12.1%-29.9%+38.0%+76.5%-40.0%-
EBITDA growth-1.4%+15.0%-44.1%+53.2%+103.7%-60.0%-
PBT growth-0.8%+11.0%-50.8%+33.9%+229.9%-72.7%-7.7%
Net income growth-13.8%+40.6%-55.2%+24.4%+205.7%-69.4%-
Revenue CAGR (3Y)-9.1%+2.8%+19.5%+13.5%+0.3%-2.1%+21.3%
EBITDA CAGR (3Y)-14.1%-0.5%+20.4%+7.7%-6.2%+0.1%+30.8%
Profitability & leverage
Net income margin+7.4%+7.5%+6.7%+10.1%+10.9%+6.9%+12.9%
Return on capital employed+8.2%+9.8%+9.1%+19.4%+17.0%+7.5%+23.6%
Return on net worth+6.0%+7.6%+6.1%+15.6%+15.1%+6.5%+22.5%
Debt / equity0.110.150.210.260.290.320.40
Long-term debt / equity0.050.090.120.110.110.130.17
Interest cover18.0126.2832.1016.8315.8855.7317.23
Efficiency & per share
Fixed asset turnover1.141.231.171.901.550.951.85
Inventory turnover10.589.898.9512.5911.657.8610.70
Debtors turnover4.916.695.527.616.844.096.17
EPS (₹)81.7287.2569.03149.45117.0941.74130.59
Dividend per share (₹)20.0020.0014.0027.5022.507.5012.50
Book value per share (₹)1,373.961,334.361,205.581,050.26867.04679.98605.92
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue151148158160154165170163
Revenue growth (YoY)-2.1%-10.3%-6.8%-1.5%+1.6%---
Other income4.004.273.545.0311.667.744.895.09
Total expenses131130134134130133146140
EBITDA20.1417.7324.9326.6824.0532.2223.9422.52
EBITDA margin+13.3%+12.0%+15.7%+16.6%+15.6%+19.5%+14.1%+13.8%
Depreciation10.8411.6412.3412.3412.3212.6412.1312.89
Interest1.521.521.672.412.462.793.122.82
Profit before tax11.788.8414.4616.9620.9324.5313.5811.90
Tax2.862.253.624.335.355.272.932.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue621650580827599339566
Revenue growth-4.4%+12.1%-29.9%+38.0%+76.5%-40.0%-
Other income24.5028.7125.1617.8128.3817.2117.39
Total expenses528555497680503292448
Employee cost73.2666.6361.5860.3051.4144.4249.08
EBITDA93.3994.6882.3214796.1247.24118
EBITDA margin+15.0%+14.6%+14.2%+17.8%+16.0%+13.9%+20.8%
Depreciation48.6449.9937.6033.0229.7328.5125.90
Interest8.0611.7414.3519.2310.5410.4115.85
Profit before tax61.1961.6655.5311384.2325.5393.52
Tax15.5512.9216.9529.3218.842.2320.58
Net profit46.4653.9038.3485.4868.7222.4873.36
Net profit margin+7.5%+8.3%+6.6%+10.3%+11.5%+6.6%+13.0%
EPS (₹)81.7287.2669.04149.46117.0941.74130.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital5.595.595.595.595.595.595.59
Reserves & surplus762740668581479374333
Shareholders' funds (net worth)767745673587484380338
Secured loans17.468.7710.2241.9592.4962.4772.59
Unsecured loans56.9785.6911310344.5548.3853.42
Total debt74.4394.46123145137111126
Total liabilities845843799735625494468
Assets
Gross block557528528465404370343
Net block343360397365295287287
Capital work in progress4.605.076.1424.1516.0713.9318.63
Investments317328321238196142118
Inventories50.3267.1364.3565.2366.1536.7249.67
Sundry debtors15010391.8611899.1875.9989.68
Cash & bank balances11510130.5625.4851.0022.111.12
Loans & advances20.7629.9426.8225.5327.7318.6818.04
Total current assets337301214234244154159
Total current liabilities87.5080.1361.9472.1169.6846.7764.07
Net working capital24922115216217410794.44
Total assets845843799735625494468
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash56.498.055.501.5915.390.410.41
Net cash from operating activities78.4713597.8011147.1034.43111
Net cash from investing activities(37.50)(30.46)(31.56)(13.02)(70.11)(16.76)(33.35)
Net cash from financing activities(39.65)(56.17)(63.69)(93.91)9.22(2.70)(77.24)
Net change in cash1.3248.442.553.90(13.79)14.980.00
Closing cash11510130.5625.4851.0022.111.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-4.4%+12.1%-29.9%+38.0%+76.5%-40.0%-
EBITDA growth-1.4%+15.0%-44.1%+53.2%+103.5%-59.9%-
PBT growth-0.8%+11.0%-50.8%+33.9%+229.9%-72.7%-7.7%
Net income growth-13.8%+40.6%-55.2%+24.4%+205.7%-69.4%-
Revenue CAGR (3Y)-9.1%+2.8%+19.5%+13.5%+0.3%-2.1%+21.3%
EBITDA CAGR (3Y)-14.1%-0.5%+20.3%+7.7%-6.2%+0.1%+30.8%
Profitability & leverage
Net income margin+7.4%+7.5%+6.7%+10.1%+10.9%+6.9%+12.9%
Return on capital employed+8.2%+9.8%+9.1%+19.4%+17.0%+7.5%+23.6%
Return on net worth+6.0%+7.6%+6.1%+15.6%+15.1%+6.5%+22.5%
Debt / equity0.110.150.210.260.290.330.42
Long-term debt / equity0.050.090.120.110.110.150.19
Interest cover18.0126.2732.0916.8315.8855.5817.23
Efficiency & per share
Fixed asset turnover1.141.231.171.901.550.951.85
Inventory turnover10.589.898.9512.5911.657.8610.70
Debtors turnover4.916.695.527.616.844.106.18
EPS (₹)81.7287.2669.04149.46117.0941.74130.59
Dividend per share (₹)20.0020.0014.0027.5022.507.5012.50
Book value per share (₹)1,374.001,334.391,205.611,050.28867.06679.99605.93

Web traffic of Transpek

The website of Transpek (transpek.com) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 41.4% vs previous month

Similar websites

Websites whose visitors overlap most with Transpek. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Fairchild
fairchildproducts.com
76%
View details

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as Transpek (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
DFPCL
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Scimplify
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Himadri Chemicals and Industries
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 515.01 M1,161
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Transpek

RSD Finance Ltd leads gainers in 'B' group | Capital Market News - Business Standard
Business Standard • 3 months ago
Transpek Standalone December 2024 Net Sales at Rs 170.04 crore, up 14.64% Y-o-Y
Moneycontrol • 1 year ago
Transpek Industry schedules board meeting
India Infoline • 1 year ago
Transpek Industry Q4 Results Live : profit falls by 74.8% YOY
Livemint • 2 years ago
India's Transpek Industry June-Quarter Consol Net Profit Falls
Reuters • 3 years ago
Transpek Industry March-Qtr Consol Net Profit Rises
Reuters • 3 years ago
India's Transpek Industry Ltd Dec-Quarter Consol Net Profit Rises
Reuters • 3 years ago
India's Transpek Industry Sept-Quarter Consol Net Profit Rises
Reuters • 4 years ago
CRISIL assigns credit ratings to Transpek Industry's bank facilities stock tumbles over 3.5%
Indiainfoline • 4 years ago
Transpek Industry appoints Avtar Singh as Joint Managing Director
Indiainfoline • 5 years ago
Premium access

Complete news archive for Transpek

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Transpek

Transpek was founded in 1965.

Transpek is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

Transpek has 930 employees.

The primary company behind Transpek, Transpek Industry Limited, reported revenue of ₹646 Cr for FY 2026, down 4% year on year.

Transpek, established in 1965 and currently in Public stage, focuses on chemicals and materials, diversified chemicals, and diversified. Manufacturer of agrochemicals, polymers, pharmaceuticals, dyestuff, and surfactants. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Transpek offers Thionyl Chloride, Acid Chlorides, and Alkyl Chlorides.

Yes, Transpek is publicly traded on BSE under the ticker symbol TRANSPEK.

Transpek is associated with 2 legal entities: Transpek Industry Limited, Transpek Creative Chemistry Private Limited.

The legal entities of Transpek currently have 15 directors, including Ashwin Champraj Shroff, Ravi Ashwin Shroff, Dipesh Kantisen Shroff and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available